Newsletter January 2024 No.219

Top News

Special Session at the 10th Nikkei-FT Conference on Infectious Diseases Toward Building a Drug Discovery Ecosystem in the Infectious Disease Field: A Year in Review and Future Initiatives

On October 17, 2023, a special session of JPMA was held at the 10th Nikkei-FT Conference on Infectious Diseases. The theme of the session was "Toward the Establishment of a Drug Discovery Ecosystem in the Field of Infectious Diseases: A Year in Review and Future Initiatives," and based on the progress made since 2022, the issues and strategies necessary to make the drug discovery ecosystem in the field of infectious diseases sustainable were discussed from the perspective of industry, academia, and government.

Topics

Explanation

Considering Risk Communication -Overview of Risk Communication and the Ideal Consent Explanation Document

Policy Research Institute

Nationality of Patent Generating Organizations for NME Approved Products in Japan, US, and Europe Comparison of Approved Products Containing New Active Pharmaceutical Ingredients in Japan, US, and Europe

From JPMA

At the Beginning of the Year 2024

Information

Share this page

TOP